Detailed Notes on Multiple system atrophy treatment vasant Kunj
However, procedural associated adverse occasions (smaller ischemic brain lesions on intra-arterial infusion) lifted basic safety worries. This has prompted the carry out of A further phase I trial revisiting the safety and tolerability of intra-arterial (carotid arteries) injection of autologous bone marrow-derived mesenchymal stem cells in MSA-C p